共 50 条
- [31] Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose studyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (04) : 913 - +Guttman-Yassky, EmmaSilverberg, Jonathan I.Nemoto, OsamuForman, Seth B.Wilke, AugustPrescilla, Randyde la Pena, AmparoNunes, Fabio P.Janes, JonathanGamalo, MargaretDonley, DavidPaik, JimDeLozier, Amy M.Nickoloff, Brian J.Simpson, Eric L.
- [32] Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind StudyJOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (10) : 1192 - 1196Gottlieb, AliceMenter, AlanArmstrong, AprilOcampo, ChristopherGu, YihuaTeixeira, Henrique D.
- [33] Onercept for moderate-to-severe Crohn's disease: A randomized, double-blind, placebo-controlled trialCLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (07) : 888 - 893Rutgeerts, PaulSandborn, William J.Fedorak, Richard N.Rachmilewitz, DanielTarabar, DinoGibson, PeterNielsen, Ole HaagenWild, GarySchreiber, StefanRossi, Claudia PenaZignani, Monia
- [34] Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trialsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (04) : 784 - 791Mendes-Bastos, PedroLadizinski, BarryGuttman-Yassky, EmmaJiang, PingLiu, JohnPrajapati, Vimal H.Simpson, Eric L.Vigna, NamitaTeixeira, Henrique D.Barbarot, Sebastien
- [37] Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b StudyDERMATOLOGY AND THERAPY, 2024, 14 (12) : 3351 - 3366Gooderham, MelindaGuttman-Yassky, EmmaIgawa, KenKabashima, KenjiEsfandiari, EhsanollahRylands, Angela J.Williams, AngelaNixon, AnnabelDent, Jennifer E.Simpson, Eric
- [38] Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized studyJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 403 - 410Bissonnette, R.Haydey, R.Rosoph, L. A.Lynde, C. W.Bukhalo, M.Fowler, J. F.Delorme, I.Gagne-Henley, A.Gooderham, M.Poulin, Y.Barber, K.Jenkin, P.Landells, I.Pariser, D. M.
- [39] EFFICACY AND SAFETY OF CM310 IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2B TRIAL IN CHINAACTA DERMATO-VENEREOLOGICA, 2022, 102 : 20 - 20Zhang, JianzhongYang, BinLi, JingyiDing, YangfengWu, LimingZhang, LitaoWang, JinyanZhu, XiaohongZhang, FurenTao, XiaohuaLi, YumeiZhang, ChunleiLi, LinfengLu, JianyunDiao, QingchunLu, QianjinMan, XiaoyongLi, FuqiuXia, XiujuanCheng, HaoZhao, YanChen, BoYan, JinchunZhao, GuoqingJia, Yingmin
- [40] EFFICACY AND SAFETY OF DUPILUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN CHINESE ADULTS: A MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIALACTA DERMATO-VENEREOLOGICA, 2021, 101 : 58 - 58Zhao, YanWu, LimingLu, QianjinGao, XinghuaZhu, XiaohongYao, XuLi, LinfengLi, WeiDing, YangfengSong, ZhiqiangLiu, LinglingDang, NingningZhang, ChunleiLiu, XiaomingGu, JunWang, JinyanGeng, SonghaiLiu, QunazhongGuo, YifengLv, DongRen, GongYang, XiuminDeng, DanqiLi, ShanshanHan, XiupingBiao, ShuzhenZheng, MinDong, LiSu, HuijuanBai, LiliO'Malley, John T.Luo, JunxiangZhang, Jianzhong